Kathleen N. Moore

基本信息

Career Trajectory

Bio

She is board certified in obstetrics and gynecology as well as gynecologic oncology and hospice and palliative care.

Dr. Moore has published more than 200 peer-reviewed publications and serves on the editorial board for four academic publications. She has a clinical research interest in drug development and phase I trials.

Select Honors & Accomplishments:
Golden Pillar Award for Patient Satisfaction, 2011
Senior Resident Research Award, Magee-Women’s Hospital, 2004
Irene Mclenahan Young Investigators Award, 2002
The Best Medical Student Teaching Resident, University of Pittsburgh, 2002
Virginia Mason Award for Clinical Excellence, 2000

Research Interests

Papers共 879 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Dynamic Immune Behavior of Primary and Metastatic Ovarian Carcinoma

Elaine Stur, Fuduan Peng, Pang-ning Teng,Emine Bayraktar,Min Hu, Sara Corvigno, David J. Brown, Sanghoon Lee,Kathleen N. Moore,Nicholas W. Bateman,Kathleen M. Darcy,George L. Maxwell,Thomas P. Conrads,Nidhi Sahni, Ignacio Vázquez-García, Sohrab P. Shah,Joseph Celestino,Nicole D. Fleming, Nicholas E. Navin,Linghua Wang, Anil K. Sood

npj Precision Oncologyno. 1 (2025): 1-12

Cited0Views0WOSNATUREBibtex

Incorporating Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer

Giorgio Bogani,Kathleen N. Moore,Isabelle Ray-Coquard,Domenica Lorusso,Ursula A. Matulonis,Jonathan A. Ledermann,Antonio Gonzalez-Martin,Jean-Emmanuel Kurtz,Eric Pujade-Lauraine,Giovanni Scambia, Giuseppe Caruso,Francesco Raspagliesi,Nicoletta Colombo,Bradley J. Monk

GYNECOLOGIC ONCOLOGY (2025): 30-40

Cited0Views0WOSBibtex

Patient-reported Outcomes from the MIRASOL Trial Evaluating Mirvetuximab Soravtansine Versus Chemotherapy in Patients with Folate Receptor Α-Positive, Platinum-Resistant Ovarian Cancer: a Randomised, Open-Label, Phase 3 Trial

Toon Van Gorp,Kathleen N Moore,Gottfried E Konecny,Alexandra Leary, Yolanda García-García,Susana Banerjee,Domenica Lorusso,Jung-Yun Lee, John W Moroney, Giuseppe Caruso, Dagmara Klasa-Mazurkiewicz,Jacqueline Tromp,Lainie P Martin, Shani Breuer,Charles A Leath,David Cibula,S John Weroha,Purificación Estévez-García,David M O'Malley, Rowan E Miller,Lan Coffman,Giuseppa Scandurra, Dominique Berton, Lingling Li, Erin Zagadailov, Elisabeth J Diver,Olivier Trédan,Felix Hilpert

The Lancet Oncologyno. 4 (2025): 503-515

Cited0Views0WOSBibtex

Long-Term Survival in Patients with Low-Risk Cervical Cancer after Simple, Modified, or Radical Hysterectomy

Christopher M Tarney,Chunqiao Tian,Leslie M Randall, S Ahmed Hussain, Pouya Javadian, Sean P Cronin, Sara Drayer,John K Chan, Daniel S Kapp,Chad A Hamilton, Charles A Leath,Doris M Benbrook, Christina R Washington,Kathleen N Moore,Nicholas W Bateman,Thomas P Conrads, Neil T Phippen,G Larry Maxwell,Kathleen M Darcy

JAMA network openno. 5 (2025): e2510717-e2510717

Cited0Views0WOSBibtex

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: the Phase II NRG-GY023 Trial

Jung-Min Lee,Austin Miller,Peter G Rose, Mariam AlHilli,Christina Washington, Veena S John, Chirag A Shah,Koji Matsuo,Jean Siedel,David S Miller, Elizabeth E Hopp, Andrea O'Shea,John K Chan, Leslie S Bradford, Christopher B Morse, Christa I Nagel, Kerry J Rodabaugh,Elise C Kohn,Kathleen N Moore,Joyce F Liu

Clinical cancer research an official journal of the American Association for Cancer Research（2025）

Cited0Views0WOSBibtex

A Review of Mirvetuximab Soravtansine-Gynx in Folate Receptor Alpha-Expressing Platinum-Resistant Ovarian Cancer

Judith A Smith, Patrick Medina, Mary Miao,Kathleen N Moore

American journal of health-system pharmacy AJHP official journal of the American Society of Health-System Pharmacistsno. 10 (2025): 522-536

Cited0Views0WOSBibtex

Melanoma-associated Antigen A4: A Cancer/testis Antigen As a Target for Adoptive T-cell Receptor T-cell Therapy

Gabrielle Knafler, Alan L. Ho,Kathleen N. Moore,Seth M. Pollack,Jean-Marc Navenot,Joseph P. Sanderson

Cancer Treatment Reviewspp.102891, (2025)

Cited0Views0WOSBibtex

State of the Art: Therapies Now and Around the Corner for Gynecologic Cancers

Kathleen N Moore,Joyce F Liu,Domenica Lorusso

American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual Meetingno. 3 (2025): e473114-e473114

Cited0Views0WOSBibtex

Impact of Adding the Immune Checkpoint Inhibitor Atezolizumab to First-Line Chemotherapy on Progression-Free Survival in Poor-Prognosis Ovarian Cancer: A Retrospective Analysis from the IMagyn050 Trial

Benoit You, Charles Anderson,Sabrina Chiara Cecere, Aurore Carrot,Tashanna Myers,Florian Heitz, Sudarshan Sharma,Fatih Selçukbiricik,Carol Aghajanian, Josefin Fernebro, Stephanie Blank, Maria Elena Laudani,Premal H Thaker,Mayu Yunokawa, Lyndsay Willmott,Alla Lisyanskaya, Roberto Hegg, Yvette He, Charles Landen,Yvonne G Lin, Jesús Alarcón,Kathleen N Moore

Gynecologic oncology (2025): 66-73

Cited0Views0WOSBibtex

Assay for the Quantification of Abemaciclib, Its Metabolites, and Olaparib in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry

Kasey L. Hill, Nicole L. Abbott, Joo Young Na, Michelle Rudek,Kathleen Moore,Eudocia Q. Lee,Mitch A. Phelps

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2025)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 879 篇Author StatisticsCo-AuthorSimilar Experts